SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-015448
Filing Date
2020-08-13
Accepted
2020-08-13 08:45:17
Documents
9
Period of Report
2020-08-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 44295
2 ex4-1.htm EX-4.1 117592
3 ex5-1.htm EX-5.1 11801
4 ex5-1_001.jpg GRAPHIC 1926
5 ex10-1.htm EX-10.1 208836
6 ex99-1.htm EX-99.1 67440
7 ex99-1_001.jpg GRAPHIC 7350
8 ex99-2.htm EX-99.2 14828
9 ex99-2_001.jpg GRAPHIC 3090
  Complete submission text file 0001493152-20-015448.txt   483456
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36268 | Film No.: 201097390
SIC: 2835 In Vitro & In Vivo Diagnostic Substances